Jiangxi Bioscience (06915.HK) will launch its initial public offering from June 22 to June 25, with plans to globally sell 36,234,500 H shares.

Wisdom Finance and Economics APP news, Jiangxi Biotech (06915.HK) will be listed from June 22nd to June 25th, 2026. The company plans to globally issue 36.2345 million H shares, with approximately 10% in Hong Kong and approximately 90% in international markets (subject to redistribution and determination based on the exercise of the over-allotment option). The offer price will be between HK$9.33 and HK$13.06 per share, with a minimum of 500 shares per lot. It is expected that H shares will begin trading on the Hong Kong Stock Exchange on June 30, 2026 (Tuesday) at 9:00 am.